Background: Diffuse Large B-Cell Lymphoma (DLBCL) is the most variant of
Non-Hodgkin’s Lymphoma (NHL) and also the most common variant with secondary
intracardiac masses. Casesummary: 7 years old child presented to
emergency with acute decompensated cardiac failure, ascites and tender
hepatomegaly. 2D echo evaluation was suggestive of large intracardiac mass in
the right atrium almost completely obstructing Tricuspid valve orifice, gross
pericardial effusion and dilated Inferior Vena Cava (IVC). Emergency tumor excision
surgery was performed which revealed 4 × 4 cm pinkish firm mass arising from
anterior Tricuspid annulus which was completely excised. Child was extubated on
postoperative day (POD) 0 and was on minimal inotropic support. Ascites reduced
significantly on POD1 allowing abdominal palpation which revealed a mass in the
epigastric region. This prompted evaluation by pediatrician and oncology workup
suggestive of increased 18-Flouro Deoxy Glucose (18-FDG) uptake in the
mediastinum, abdomen, bilateral proximal thighs, all mediastinal lymph nodal
stations, bilateral lung hilar stations 10R, 10L involving all encasing the
heart and great vessels with pleural deposits, Celiac trunk, superior
Mesenteric Artery (SMA), Portal vein, IVC and abdominal aorta. Histo pathology
Examination (HPE) and Immuno Histo Chemistry (IHC) of intracardiac mass
revealed DLBCL which is metastatic in nature. Chemotherapy was started as per
(French American British Lymphomes Malins B) FAB LMB-96 protocol with the child
currently in the Induction phase having poor prognosis and less survival
interval. Conclusion: Surgery can be considered a treatment option for
metastatic intracardiac masses during emergency scenarios like cardiogenic
shock to relieve obstruction along the pathway of blood flow in the heart even
though we may not be able to completely excise the tumor surgically.
References
[1]
Swerdlow, S.H., Campo, E., Pileri, S.A., et al. (2016) The 2016 Revision of the World Health Organization Classification of Lymphoid Neoplasms. Blood, 127, 2375-2390. https://doi.org/10.1182/blood-2016-01-643569
[2]
Johri, A., Baetz, T., Isotalo, P.A., Nolan, R.L., Sanfilippo, A.J. and Ropchan, G. (2009) Primary Cardiac Diffuse Large B Cell Lymphoma Presenting with Superior Vena Cava Syndrome. Canadian Journal of Cardiology, 25, E210-E212. https://doi.org/10.1016/S0828-282X(09)70110-2
[3]
El Sayed, M.J., Gharzuddin, W. and Kharfan-Dabaja, M.A. (2014) T-Cell Acute Lymphoblastic Leukemia Presenting as a Cardiac Tamponade. Austin Journal of Emergency and Critical Care Medicine, 1, Article ID: 1007.
[4]
Majano-Lainez, R.A. (1997) Cardiac Tumors: A Current Clinical and Pathological Perspective. Critical Review in Oncogenesis, 8, 293-303. https://doi.org/10.1615/CritRevOncog.v8.i4.10
[5]
Patte, C., Auperin, A., Gerrard, M., Michon, J., Pinkerton, R., Sposto, R., Weston, C., Raphael, M., Perkins, S.L., McCarthy, K., Cairo, M.S. and FAB/LMB96 International Study Committee (2007) Results of the Randomized International FAB/LMB96 Trial for Intermediate Risk B-Cell Non-Hodgkin Lymphoma in Children and Adolescents: It Is Possible to Reduce Treatment for the Early Responding Patients. Blood, 109, 2773-2780. https://doi.org/10.1182/blood-2006-07-036673
[6]
Zaharia, L. and Gill, P.S. (1991) Primary Cardiac Lymphoma. American Journal of Clinical Oncology, 14, 142-145. https://doi.org/10.1097/00000421-199104000-00009
[7]
Curtsinger, C.R., Wilson, M.J. and Yoneda, K. (1989) Primary Cardiac Lymphoma. Cancer, 64, 521-525. https://doi.org/10.1002/1097-0142(19890715)64:2<521::AID-CNCR2820640227>3.0.CO;2-T
[8]
Petrich, A., Cho, S.I. and Billett, H. (2011) Primary Cardiac Lymphomaan Analysis of Presentation, Treatment, and Outcome Patterns. Cancer, 117, 581-589. https://doi.org/10.1002/cncr.25444
[9]
Chen, H., Qian, S., Shi, P., Liu, L. and Yang, F. (2020) A Presentation, Treatment, and Survival Analysis of Primary Cardiac Lymphoma Cases Reported from 2009 to 2019. International Journal of Hematology, 112, 65-73. https://doi.org/10.1007/s12185-020-02881-2
[10]
Voigt, P., Wienbeck, S., Weber, M.A., Oyama-Manabe, N., Beimler, M., Schob, S., et al. (2017) Cardiac Hematological Malignancies: Typical Growth Patterns, Imaging Features, and Clinical Outcome. Angiology, 69, 170-176. https://doi.org/10.1177/0003319717713581
[11]
Gordon, M.J., Danilova, O., Spurgeon, S. and Danilov, A.V. (2016) Cardiac Non-Hodgkin’s Lymphoma: Clinical Characteristics and Trends in Survival. European Journal of Haematology, 97, 445-452. https://doi.org/10.1111/ejh.12751
[12]
Aledavood, S.A., Emadi Torghabeh, A., Homaee Shandiz, F. and Memar, B. (2015) Cardiac Involvement in Non-Hodgkin Lymphoma, an Incidental Large Atrial Mass: A Case Report. International Journal of Cancer Management, 8, e3913. https://doi.org/10.17795/ijcp-3913
[13]
Habertheuer, A., Ehrlich, M., Wiedemann, D., et al. (2014) A Rare Case of Primary Cardiac B Cell Lymphoma. Journal of Cardiothoracic Surgery, 9, Article No. 14. https://doi.org/10.1186/1749-8090-9-14
[14]
Talapatra, K., Panda, S., Goyle, S., et al. (2016) Superior Vena Cava Syndrome: A Radiation Oncologist’s Perspective. Journal of Cancer Research and Therapeutics, 12, 515-519. https://doi.org/10.4103/0973-1482.177503
[15]
Jonavicius, K., Salcius, K., Meskauskas, R., et al. (2015) Primary Cardiac Lymphoma: Two Cases and a Review of Literature. Journal of Cardiothoracic Surgery, 10, Article No. 138. https://doi.org/10.1186/s13019-015-0348-0
[16]
Zelenetz, A.D., Gordon, L.I. and Abramson, J.S. (2019) NCCN Guidelines Insights: B-Cell Lymphomas, Version 3.2019. Journal of the National Comprehensive Cancer Network, 17, 650-661. https://doi.org/10.6004/jnccn.2019.0029